Following approval for professional use, personal use products also approved

On the 4th, Osang Healthcare (036220), a company specializing in in vitro diagnostics (IVD), announced that it had received Emergency Use Authorization (EUA) from the US FDA for its personal use COVID-19 and influenza combo kit.

The COVID-19 and influenza combo kit that Osang Healthcare received FDA emergency use authorization for is a diagnostic device that can simultaneously detect COVID-19 and influenza A and B. This comes about two weeks after the company received approval for its professional-use product on the 22nd of last month, making it the second personal rapid test product in the world and the first from a domestic company to receive approval.

Full article : Osang Healthcare receives US FDA emergency use authorization for personal COVID-19 and influenza combo kit